FCFloris E. A. Udink Ten Cate

Floris E. A. Udink Ten Cate

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Floris E. A. Udink Ten Cate has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical, molecular, and cardiac characterization of four rare mtDNA variants affecting mt-tRNA genes in pediatric mitochondrial disease

    by Celina V. Malyar, Evangelia Papathanasiou, Floris Udink Ten Cate, Maaike C. de Vries, Lonneke de Boer, Richard Rodenburg, Benno Kusters, Mirian Janssen, Jan Christiaan van der Meijden

    IntroductionMitochondrial diseases (MD) are genetically heterogeneous disorders caused by impaired oxidative phosphorylation (OXPHOS). Pathogenic variants in mitochondrial DNA (mtDNA) genes encoding mitochondrial transfer RNAs (mt-tRNAs) represent a significant subgroup, yet many rare variants remain poorly characterized. Cardiac involvement is recognized but may be subclinical and underdetected. This study aimed to characterize and expand the clinical, molecular, and biochemical phenotype of four rare mtDNA variants (m.4300A>G, m.4404T>C, m.7507A>G, and m.608A>G) through detailed phenotyping. In addition, we assessed cardiac involvement with electrocardiography and speckle-tracking echocardiography. MethodsWe conducted a retrospective case series of four pediatric patients at a national mitochondrial expertise center. Clinical, genetic, biochemical, and histological data were collected. Cardiac evaluation included electrocardiography, conventional echocardiography, and two-dimensional speckle-tracking strain imaging. A targeted literature review was performed for all variants. ResultsDisease onset occurred in early childhood, with phenotypes ranging from isolated mitochondrial myopathy to progressive multisystem encephalomyopathy. Cardiac symptoms were absent or mild. Mild ECG abnormalities were consistently present, including QRS fragmentation, repolarization changes, and microvoltages. Conventional echocardiography was normal in all patients. Speckle-tracking echocardiography was abnormal in two patients: one showed mildly reduced global longitudinal strain, whereas another showed regional wall-motion abnormalities despite preserved global strain. The m.4404T>C variant is reported for the first time, and the other variants extend beyond previously described organ-specific presentations. ConclusionRare mtDNA variants affecting mt-tRNA genes show marked phenotypic heterogeneity and may include subclinical cardiac abnormalities despite normal conventional echocardiography. Speckle-tracking echocardiography may add value to longitudinal cardiac phenotyping in pediatric mitochondrial disease.

  • Open Access

    Cardiac adaptation in pediatric kidney transplant recipients with large donor–recipient size discrepancy: a speckle-tracking echocardiography study

    by Mark W. Schaars, Floris E. A. Udink Ten Cate, Elisabeth A. M. Cornelissen, Gert Weijers, Marieke Voet, Anne E. C. M. Saris

    Background: Pediatric living donor kidney transplantation (KT) with large donor-recipient size mismatch induces a large hemodynamic burden on the child recipient. Although successful KT is known to be beneficial for cardiac function and remodeling, its effects in small recipients with adult donors have not been evaluated. We aimed to describe left ventricular (LV) function and geometry using conventional and speckle-tracking echocardiography in this population. Methods: A prospective longitudinal study was performed. Living donor KT recipients with large donor-recipient size mismatch underwent conventional and speckle-tracking echocardiography prior to KT, shortly after KT and at 6 and 12 months post-transplantation. LV global longitudinal strain (GLS), LV ejection fraction, cardiac index, LV mass index (LVMi) and LV dimensions were obtained. Results: Ten patients were included with a median [IQR] age of 5.9 years [4.4–8.5]. The median donor–recipient body surface area ratio was 2.36. Prior to transplantation, LV systolic dysfunction was found in 80% of the patients (GLS −18.9% [−19.7–−18.7]). Significant improvement was found after 12 months (change in GLS −1.3% [−1.8–−0.9], p = 0.004). A significant reduction in LVMi was found at 6 months and 12 months of −8.9 g/m 2.7 [−15.6–−5.4], p = 0.01 and −14.3 g/m 2.7 [−15.3–−12.9], p = 0.004, respectively. No significant changes in cardiac index were found at 6 and 12 months. Conclusions: Despite the increased hemodynamic demands after pediatric KT with large donor-recipient size mismatch, improved LV function and reduced left ventricular mass were found within 1 year after transplantation. These results suggest reversed cardiac remodeling.

  • Open Access

    Left ventricular deformation and myocardial fibrosis in pediatric patients with Duchenne muscular dystrophy

    by Thijs P. Kerstens, Wouter M. van Everdingen, Jesse Habets, Arie P.J. van Dijk, Willem A. Helbing, Dick H.J. Thijssen, Floris E.A. Udink Ten Cate


  • AKT/mTOR and MAPK Inhibition Improves Childhood RASopathic Cardiomyopathy

    by C. M. Wolf, M. Zenker, G. Norrish, M. Russell, J. K. Meisner, D. M. Peng, T. Prendiville, J. Kleinmahon, P. F. Kantor, D. Gottlieb Sen, et al.

    Background: RASopathies are a spectrum of pleomorphic syndromic disorders and caused by germline mutations in the RAS/mitogen-activated protein kinase (MAPK) pathway. They cause progressive RASopathy-associated cardiomyopathy (RAS-CM) for which no preventive or curative therapies exist. Young infants presenting with heart failure suffer from high mortality. RAS-CM presenting later in life is morbid with increased risk for sudden cardiac death or cardiac transplantation. Animal studies and limited case reports have suggested that small molecule inhibitors of target of rapamycin (mTOR) or mitogen-activated protein kinase kinase (MEK), pathways activated in certain RASopathies, are beneficial. The aim of this study is to report on 25 patients from Europe and North America with progressive and/or life-threatening RAS-CM in whom we initiated off-label or compassionate inhibition of mTOR or MEK after exhaustion of standard therapies. Method: This study was done by retrospective data collection. Results: Over a follow-up period of 296 patient-months (median, 5.5 months; range, 1.5–50), we observed increased transplant-free survival in critically ill patients <6 months of age treated with mTORi and/or MEKi as compared with that from natural history studies (75 vs. 39%, p = 0.031). Freedom from surgical intervention was 52% (11 of 21 patients in whom surgical outflow tract resection was indicated), and clinically meaningful improvement (greater than 20% from baseline) in 50% or more of preselected cardiac outcome variables occurred in 18 of 25 patients (72%) undergoing mTORi and/or MEKi treatment. No life-threatening adverse events related to mTORi or MEKi occurred. Conclusion: These data suggest that selected RASopathy patients may benefit from mechanism-informed therapeutics guided by the biological understanding of cardiac pathology in this disease spectrum. Publication Date: 12 February 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Successful biventricular cardiac resynchronization therapy in a failing Fontan patient: Implications of ventriculo‐ventricular interdependency in single ventricle physiology

    by Floris E. A. Udink Ten Cate, Ingo Germund, Stijn S. Goossens, Gerardus Bennink, Narayanswami Sreeram

    We describe a Fontan patient with severe heart failure who was successfully treated with biventricular cardiac resynchronization therapy (CRT). Our case shows that strain imaging might play a crucial role in guiding placement of pacing leads and in characterizing the electromechanical substrate associated with a favorable CRT response. Furthermore, we demonstrate for the first time that ventriculo‐ventricular interdependency seems an important mechanical concept, which can be utilized to augment cardiac performance in failing Fontan patients with a functional hypoplastic ventricle.


  • Off‐label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience

    by Floris E.A. Udink Ten Cate, Rodina Sobhy, Atul Kalantre, Sakshi Sachdev, Anand Subramanian, Nageswara Rao Koneti, Raman Krishna Kumar, Hala Hamza, Mahimarangaiah Jayranganath, Narayanswami Sreeram

    Objective: We sought to evaluate the feasibility, technical aspects, and outcome of transcatheter perimembranous ventricular septal defect (pmVSD) closure using duct occluder devices with a single retention disc.Background: Use of duct occluder devices to close pmVSD seems a promising alternative therapy. However, limited data exist on this technique.Methods: From 2010 to 2016, 222 patients (female 47.7%) were identified from databases of five participating institutions in whom pmVSD closure was attempted using an Amplatzer Duct Occluder I or Lifetech duct occluder device.Results: Patients ranged in age from 0.7 to 52 years (median, 7.0 years) and in weight from 4.0 to 70 kg (median, 18.0 kg). The mean size of the VSD was 6.8 ± 2.2 mm. A large defect (> 6 mm) was present in 137 patients (61.7%). Device closure was successful in 218 patients (98.2%). The 10/8 mm device was used in most patients (n = 85, 38.3%), and the vascular approach was from the femoral vein in 169 patients (76.1%). There were 18 early complications in 17/218 patients (7.8%). Three patients (1.4%) developed complete heart block (transient n = 2; requiring permanent pacing n = 1). Median follow‐up was 6 months (6 months–6 years). A mild residual shunt was seen in 10 patients at 6 months follow‐up.Conclusions: The immediate results of transcatheter pmVSD closure using a duct occluder device with a single retention disc are promising. It is an effective technique with a lower rate of complications than for other currently available devices.


  • Inhomogeneous Longitudinal Cardiac Rotation and Impaired Left Ventricular Longitudinal Strain in Children and Young Adults with End‐Stage Renal Failure Undergoing Hemodialysis

    by Ruth Lagies, Bodo B. Beck, Bernd Hoppe, Sahar S. Sheta, Verena Weiß, Narayanswami Sreeram, Floris E. A. Udink Ten Cate

    Cardiac dysfunction frequently complicates the clinical course of patients with end-stage renal failure (ESRF). Recently, we observed abnormal longitudinal cardiac rotation (LR) among patients with ESRF. In this study, we sought to quantify LR mechanics in patients undergoing hemodialysis (HD). Twenty-four subjects, 12 ESRF patients (58% male; age 17.5 ± 4.4 years) receiving HD, and 12 aged-matched controls, were prospectively studied. Patients underwent echocardiographic studies before and after HD. LR mechanics were quantified with two-dimensional speckle tracking echocardiography. Peak systolic left ventricular (LV) longitudinal strain and displacement measurements were obtained in all subjects. LR mechanics were successfully quantified in all subjects using 5 key echocardiographic features of LR. We identified two different inhomogeneous LR motion patterns in 41.7% of ESRF patients, characterized by a delayed timing of LR or increased segmental apical rotation. Inhomogeneous LR patterns were not found in controls. Timing of early-systolic counterclockwise LR increased after HD (P = 0.006). In patients, late-systolic clockwise LR occurred earlier (P = 0.043), and showed a significant prolongation after HD (P = 0.003). Longitudinal strain was significantly impaired in patients (P = 0.015), and further decreased after HD (P < 0.0001). Strong correlations were observed between strain and displacement parameters and LR mechanics. Quantifying LR using speckle tracking echocardiography was feasible, easy, and reproducible. Inhomogeneous LR motion patterns were demonstrated in a large proportion of patients with ESRF. LV dysfunction seems the most important determinant of inhomogeneous LR. Further studies are required to validate these findings.


  • Open Access

    Pacing Therapy in Infants and Children with Congenital and Acquired Complete Atrioventricular Block: Optimal Pacing Strategies, Management, and Follow-up

    by Floris E.A. Udink Ten Cate, Narayanswami Sreeram

    Pacing Therapy in Infants and Children with Congenital and Acquired Complete Atrioventricular Block: Optimal Pacing Strategies, Management, and Follow-up | InTechOpen, Published on: 2011-02-14. Authors: Floris E.A. Udink ten Cate and Narayanswami Sreeram